Demystifying Severe Cutaneous Adverse Reactions (SCAR) to Drugs
Monday, March 6, 2017: 10:45 AM-12:00 PM
Georgia World Congress Center, Building B, Level 5, Thomas B. Murphy Ballroom 3-4
1.25 CME/CE
Luz S. Fonacier , MD FAAAAI

Learning Objectives:
  1. Discuss the definitions, mechanisms and epidemiology of SCAR to drugs
  2. Describe the genetic predisposition and implications for genetic testing in SCAR to drugs
  3. Review the present state of treatment options for SCAR to drugs
This Session Will Use Audience Response Technology.
10:45 AM
Definitions, Mechanisms and Epidemiology
Daniel Yerly, MD
11:05 AM
Question & Answer
11:10 AM
Genetics and Predictive Tests
David A. Ostrov, PhD
11:30 AM
Question & Answer
11:35 AM
Treatment Controversies
Syed Shahzad Mustafa, MD FAAAAI
11:55 AM
Question & Answer
See more of: Session